Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
STRONGTREAT: Multiple vs Single Dose Ivermectin for Strongyloidiasis
NCT01570504Phase 3Completed
- Sponsor
- Centro per le Malattie Tropicali
- Start
- Mar 2013
- Primary completion
- Jun 2018
- Modality
- Small Molecules
- Countries
- 3
01
Overview
A Phase 3 trial of CHILD-IVITAB in strongyloidiasis, sponsored by Centro per le Malattie Tropicali. Started Mar 2013; status: completed.
02
Drugs
CHILD-IVITAB
03
Conditions
strongyloidiasis
Beyond the preview
Go deeper on NCT01570504.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01570504.